From Across the Pond: Expert Insight on Life Science Start-ups

Nov 7 2017https://www.eventbrite.com/e/from-across-the-pond-expert-insight-on-life-science...

It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for a special presentation from Jeanne Bolger on learning the tricks of the trade in preparing a non-confidential deck and executive summary. She will share practical tips on becoming more effective in communicating your story to Angel investors and VCs, increasing your chances of successful fundraising.

After Jeanne’s presentation, join us for a panel discussion on becoming a life science entrepreneur in both Canada and Ireland.

Speakers
Jeanne Bolger | VP, Venture Investments, Johnson & Johnson Innovation - JJDC read bio»
Alan Hobbs | Manager High Potential Start Ups, Enterprise Ireland read bio»
Sandra Ganly | Operations Manager , BioInnovate read bio»
Anne O’Riordan | Global Industry Senior Managing Director, Accenture read bio»

Agenda:
4:00 | Registration Opens and Networking
4:30 | Presentation
5:15 | Q&A
5:30 | Panel
6:00 | Cocktail Reception
7:00 | Program Close

Who should attend:
This event is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.

Fees:
$15 | General Public
Includes presentation, Q&A, and lunch.

Location:
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Speaker Biographies:
Jeanne Bolger | VP, Venture Investments, Johnson & Johnson Innovation - JJDC
Jeanne joined Johnson & Johnson Innovation - JJDC as Vice President, Venture Investments, in February 2013. She is based in London, UK at the Johnson & Johnson Innovation Centre. Jeanne's responsibilities are focused on investing in and managing portfolio investments in the pharmaceuticals and biotechnology areas in Europe.
Jeanne has over 25 years of pharmaceutical industry experience in management roles across R+D, Commercial and Business Development. She spent 11 years in Licensing and Acquisition, most recently as Global Head of Scientific Licensing for Johnson & Johnson's Pharmaceutical business, having joined the Johnson & Johnson Family of Companies in 2005 from the Business Development group at GSK.
In 2009, Jeanne became VP Alliance Management and Board Director at Janssen Alzheimer Immunotherapy, working with Pfizer and Elan on immunotherapies targeting beta amyloid for Alzheimer's disease.
Jeanne received her medical degree from University College Dublin. She also holds diplomas in Child Health (NUI) and in Finance and Accounting (ACCA). She is a Fellow of the Royal Academy of Medicine of Ireland (RAMI). She has served as the sole pharmaceutical industry representative on two Irish government taskforces seeking to enhance the commercialization of IP from Irish academic centres. She is a visiting lecturer on the MSc Pharmaceutical Medicine curriculum at Trinity College in Dublin, Ireland.


Alan Hobbs | Manager High Potential Start Ups, Enterprise Ireland
Alan manages the Irish Government’s lifescience High Potential Start-Up team who work with the best emerging Bio, Pharma and Medical Device companies in Ireland. He has 27 years global experience living and working in China, Silicon Valley, Taiwan, Korea and Ireland. Alan started his career working with “C” level executives in US and Asian Multinationals, selling Ireland as a HQ for their EMEA activities, he crossed over to the domestic side of economic development with roles in High Growth Markets, Corporate Communications and the Food sector. MBA graduate from Trinity College, currently lives in Dublin with Yvonne, Thomas and Conor, cats (Nellie and Bill) and Peanut the dog.

Enterprise Ireland is the Agency of the Irish Government responsible for the Development of Irish Industry. They work with 5000 clients across a wide range of sectors to help entrepreneurs start, scale and succeed in Global markets. More information available at: www.enterprise-ireland.com


Sandra Ganly | Operations Manager , BioInnovate
Sandra Ganly is a biomedical engineer with 14 years industrial and innovative product design experience in the medical device industry, progressing from technician and engineering roles to leadership positions in both Industry and Academia. She conducted her PhD research in Next Generation Coronary Stents and holds a senior research fellow position in NUI Galway’s Cardiovascular Research Institute where she continues her Preventive Cardiology and Risk-factor research interests. Since 2008, Sandra has maintained a role at the interface of academic, business and clinical communities, successfully managing multi-disciplinary projects for the benefit of the Medtech sector in Ireland – including the establishment of a Masters in Medical Technology Regulatory Affairs and BioInnovate Ireland - a Medical Device Innovation programme modelled on the prestigious Stanford Biodesign programme. As BioInnovate’s commercial lead, Sandra has assisted 19 technology solutions transition from their proof-of-concept origins in academia to raising investment in the market. Sandra was recently appointed as a Director in a newly funded mentor-centric Medtech Accelerator, BioExel, which aims to further support early stage and has a longer-term ambition to raise a consortium fund with Angels, Corporates and Government for Medtech start-ups in Ireland. Sandra is also the Chief Technology Officer for her own technology company, Contego Medical, focused on developing innovative solutions for unmet clinical needs in Sports-acquired Brain Injury.


Anne O’Riordan | Global Industry Senior Managing Director, Accenture
Anne is the global Industry Senior Managing Director for Accenture’s Life Sciences business and a global client lead. She has been with Accenture for 27 years. Over this period she has worked across the US, Europe and Asia with global companies transforming their business and operating models, to meet changing market and portfolio needs. She has been in China since 2007 and has been on the board of the global Products Operating Group of Accenture since 2006. She has published numerous articles over the past 20+ years. Her most recent publication is a book entitled ‘Healthcare Disrupted: Next Generation Business Models and Strategies@ (Wiley Feb 2016)”.  Based in Hong Kong, Ms. O’Riordan is a member of The Women’s Foundation, the 30% Club and co-chair of the Women of Influence Committee at the American Chamber of Commerce.

Share